Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Achieve Life Sciences Inc 1040 West Georgia Street Suite 1030 Vancouver BC V6E 4H1 CAN

www.achievelifesciences.com Employees: 25 P: 604-210-2217

Sector:

Medical

Description:

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.

Key Statistics

Overview:

Market Capitalization, $K 234,572
Enterprise Value, $K 221,952
Shares Outstanding, K 51,105
Annual Sales, $ 0 K
Annual Net Income, $ -39,830 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -12,720 K
EBIT, $ -50,110 K
EBITDA, $ -49,860 K
60-Month Beta 1.62
% of Insider Shareholders 3.00%
% of Institutional Shareholders 33.52%
Float, K 49,572
% Float 97.00%
Short Volume Ratio 0.33

Growth:

1-Year Return -8.20%
3-Year Return 115.70%
5-Year Return -52.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 08/07/25
Next Earnings Date 11/06/25
Earnings Per Share ttm -1.46
EPS Growth vs. Prev Qtr 24.32%
EPS Growth vs. Prev Year 22.22%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/31/20

ACHV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -215.58%
Return-on-Assets % -125.70%
Profit Margin % 0.00%
Debt/Equity 0.03
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.65
Book Value/Share 0.84
Interest Coverage -17.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar